The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Giacobello Scott M. since 2019.
This trader's CIK number is 1754154.
At the time of last reporting, Giacobello Scott M. was the CHIEF FINANCIAL OFFICER of Whitehawk Therapeutics, Inc.. (stock ticker symbol WHWK).
Also see all insider trading activities at Whitehawk Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | GWPH | 0 | $0 | 0 | $0 | 155,448 | $155 |
| 2020 | GWPH | 7,200 | $48,960 | 6,072 | $53,836 | 116,604 | $116 |
| 2019 | GWPH | 0 | $0 | 9,456 | $126,313 | 18,540 | $18 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | WHWK | 0 | $0 | 0 | $0 | 473,902 | $0 |
| 2025 | WHWK | 0 | $0 | 2,806 | $6,594 | 6,750 | $0 |
1. Gw Pharmaceuticals Plc (GWPH)
2. Whitehawk Therapeutics, Inc. (WHWK)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-26 | GWPH | Option Ex | 149,160 | .00 | 149 |
| 2021-03-01 | GWPH | Option Ex | 6,288 | .00 | 6 |
| 2020-05-18 | GWPH | Option Ex | 116,604 | .00 | 116 |
| 2020-03-13 | GWPH | Buy | 7,200 | 6.80 | 48,960 |
| 2020-03-02 | GWPH | Sale | 2,220 | 8.34 | 18,514 |
| 2020-02-26 | GWPH | Sale | 3,852 | 9.17 | 35,322 |
| 2019-05-20 | GWPH | Sale | 4,224 | 14.52 | 61,332 |
| 2019-05-18 | GWPH | Option Ex | 8,136 | .00 | 8 |
| 2019-02-26 | GWPH | Option Ex | 10,404 | .00 | 10 |
| 2019-02-26 | GWPH | Sale | 5,232 | 12.42 | 64,981 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-04-01 | WHWK | Option Ex | 473,902 | .00 | 0 |
| 2025-03-01 | AADI | Option Ex | 6,750 | .00 | 0 |
| 2025-03-03 | AADI | Sale | 2,806 | 2.35 | 6,594 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Giacobello Scott M. (CHIEF FINANCIAL OFFICER of Whitehawk Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.